MRE11 and breast cancer: We demonstrate that cyclin A2 plays a vital role in maintaining adequate levels of MRE11 and RAD51 proteins for proper functioning of HR repair and that its loss sensitizes the breast cancer cells to DNA damaging agents and PARP inhibitors.